<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01501019</url>
  </required_header>
  <id_info>
    <org_study_id>Exercise in Autoimmunity</org_study_id>
    <nct_id>NCT01501019</nct_id>
  </id_info>
  <brief_title>Exercise in Sjogren, Myositis and Takayasu's Arteritis</brief_title>
  <official_title>Effects of Exercise Training in Primary Sjogren´s Syndrome, Myositis and Takayasu's Arteritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exercise may improve physical capacity and health parameters in Primary Syndrome´s Sjogren,
      Myositis and Takayasu's Arteritis.

      Therefore, this study aims to investigate the role of an exercise training program in
      patients with Primary Syndrome´s Sjogren, Myositis and Takayasu's Arteritis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aerobic Capacity</measure>
    <time_frame>Twelve weeks</time_frame>
    <description>Maximum Oxygen Consumption (VO2Max)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>Twelve weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Twelve weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum anti-inflammatory cytokines</measure>
    <time_frame>Twelve weeks</time_frame>
    <description>Interleukin-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum pro-inflammatory cytokines</measure>
    <time_frame>Twelve weeks</time_frame>
    <description>Interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum inflammatory markers</measure>
    <time_frame>Twelve weeks</time_frame>
    <description>erythrocyte sedimentation rate (ESR), c-reactive protein (CRP), aldolase</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Primary Sjogren´s Syndrome</condition>
  <condition>Myositis</condition>
  <arm_group>
    <arm_group_label>Sjogren and Myositis Control (no control for takayasu's)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sjogren, Myositis and Takayasu's Trained</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>&quot;Sjöegren arm&quot;: 30-60 minutes of combined aerobic and strength exercises, twice a week, moderate intensity.
&quot;Myositis arm&quot;: 30 minutes of resistance training combined partial blood flow restriction, twice a week, low intensity.
&quot;Takayasu's arteritis arm&quot;: 30-50 minutes of aerobic, twice a week, moderate intensity.</description>
    <arm_group_label>Sjogren, Myositis and Takayasu's Trained</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physically inactive

          -  Stable drugs regime for at least three months

        Exclusion Criteria:

          -  Other rheumatic diseases

          -  Physical disability that prevent the patient to perform the physical tests

          -  Severe pulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Sao Paulo School of Medicine Clinical Hospital</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thalita Blasques Dassouki, MSc</last_name>
      <phone>55 11 2661-8022</phone>
      <email>thatausp@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Ana Lucia Sa Pinto, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno Gualano, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernanda R Lima, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hamilton Roschel, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra G Pasoto, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2011</study_first_submitted>
  <study_first_submitted_qc>December 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2011</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Bruno Gualano</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Myositis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

